Hollsteen
← F5

Research and development

Flow – sum over the period · $M

QuartersFiscal years

$MResearch and development · Q1 FY2016: $81.0M · 10-Q 0001048695-16-000026 filed Jan 27, 2016Research and development · Q2 FY2016: $86.0M · 10-Q 0001048695-16-000035 filed Apr 27, 2016Research and development · Q3 FY2016: $83.0M · 10-Q 0001048695-16-000041 filed Jul 27, 2016Research and development · Q4 FY2016: $84.0M · 10-K 0001048695-16-000049 filed Nov 4, 2016Research and development · Q1 FY2017: $87.0M · 10-Q 0001048695-17-000008 filed Feb 1, 2017Research and development · Q2 FY2017: $89.0M · 10-Q 0001048695-17-000016 filed May 10, 2017Research and development · Q3 FY2017: $89.0M · 10-Q 0001048695-17-000022 filed Aug 2, 2017Research and development · Q4 FY2017: $85.0M · 10-K 0001048695-17-000028 filed Nov 3, 2017Research and development · Q1 FY2018: $86.0M · 10-Q 0001048695-18-000005 filed Feb 2, 2018Research and development · Q2 FY2018: $91.0M · 10-Q 0001048695-18-000017 filed May 2, 2018Research and development · Q3 FY2018: $94.0M · 10-Q 0001048695-18-000025 filed Aug 1, 2018Research and development · Q4 FY2018: $95.0M · 10-K 0001048695-18-000031 filed Nov 21, 2018Research and development · Q1 FY2019: $92.0M · 10-Q 0001048695-19-000008 filed Feb 1, 2019Research and development · Q2 FY2019: $96.0M · 10-Q 0001048695-19-000014 filed May 3, 2019Research and development · Q3 FY2019: $117M · 10-Q 0001048695-19-000030 filed Aug 2, 2019Research and development · Q4 FY2019: $103M · 10-K 0001048695-19-000034 filed Nov 15, 2019Research and development · Q1 FY2020: $96.0M · 10-Q 0001048695-20-000012 filed Feb 5, 2020Research and development · Q2 FY2020: $109M · 10-Q 0001048695-20-000027 filed May 6, 2020Research and development · Q3 FY2020: $116M · 10-Q 0001048695-20-000035 filed Aug 5, 2020Research and development · Q4 FY2020: $120M · 10-K 0001048695-20-000041 filed Nov 19, 2020Research and development · Q1 FY2021: $114M · 10-Q 0001048695-21-000009 filed Feb 5, 2021Research and development · Q2 FY2021: $140M · 10-Q 0001048695-21-000021 filed May 6, 2021Research and development · Q3 FY2021: $133M · 10-Q 0001048695-21-000033 filed Aug 5, 2021Research and development · Q4 FY2021: $125M · derived · 10-K 0001048695-22-000033 filed Nov 15, 2022Research and development · Q1 FY2022: $130M · 10-Q 0001048695-22-000007 filed Feb 4, 2022Research and development · Q2 FY2022: $136M · 10-Q 0001048695-22-000015 filed May 6, 2022Research and development · Q3 FY2022: $139M · 10-Q 0001048695-22-000025 filed Aug 5, 2022Research and development · Q4 FY2022: $139M · derived · 10-K 0001048695-23-000039 filed Nov 14, 2023Research and development · Q1 FY2023: $142M · 10-Q 0001048695-23-000011 filed Feb 3, 2023Research and development · Q2 FY2023: $141M · 10-Q 0001048695-23-000018 filed May 5, 2023Research and development · Q3 FY2023: $129M · 10-Q 0001048695-23-000030 filed Aug 4, 2023Research and development · Q4 FY2023: $128M · derived · 10-K 0001048695-24-000185 filed Nov 18, 2024Research and development · Q1 FY2024: $120M · 10-Q 0001048695-24-000012 filed Feb 5, 2024Research and development · Q2 FY2024: $122M · 10-Q 0001048695-24-000079 filed May 6, 2024Research and development · Q3 FY2024: $124M · 10-Q 0001048695-24-000125 filed Aug 6, 2024Research and development · Q4 FY2024: $124M · derived · 10-K 0001048695-25-000157 filed Nov 25, 2025Research and development · Q1 FY2025: $131M · 10-Q 0001048695-25-000026 filed Feb 7, 2025Research and development · Q2 FY2025: $137M · 10-Q 0001048695-25-000091 filed May 6, 2025Research and development · Q3 FY2025: $136M · 10-Q 0001048695-25-000129 filed Aug 6, 2025Research and development · Q4 FY2025: $136M · derived · 10-K 0001048695-25-000157 filed Nov 25, 2025Research and development · Q1 FY2026: $141M · 10-Q 0001048695-26-000023 filed Feb 5, 2026Research and development · Q2 FY2026: $151M · 10-Q 0001048695-26-000051 filed May 5, 2026Research and development · Q3 FY2026: $165M · 10-Q 0001048695-26-000067 filed Aug 6, 202696.3164.781.1Q1 FY2016Q3 FY2026Q2 FY2019
$MResearch and development · Q2 FY2018: $91.0M · 10-Q 0001048695-18-000017 filed May 2, 2018Research and development · Q3 FY2018: $94.0M · 10-Q 0001048695-18-000025 filed Aug 1, 2018Research and development · Q4 FY2018: $95.0M · 10-K 0001048695-18-000031 filed Nov 21, 2018Research and development · Q1 FY2019: $92.0M · 10-Q 0001048695-19-000008 filed Feb 1, 2019Research and development · Q2 FY2019: $96.0M · 10-Q 0001048695-19-000014 filed May 3, 2019Research and development · Q3 FY2019: $117M · 10-Q 0001048695-19-000030 filed Aug 2, 2019Research and development · Q4 FY2019: $103M · 10-K 0001048695-19-000034 filed Nov 15, 2019Research and development · Q1 FY2020: $96.0M · 10-Q 0001048695-20-000012 filed Feb 5, 202096.396.091.1116.9Q2 FY2018Q1 FY2020Q2 FY2019
Q2 FY2019
96.3$M
All values (43)
PeriodValue ($M)Status
Q3 FY2026164.7reported
Q2 FY2026151.0reported
Q1 FY2026141.2reported
Q4 FY2025136.4derived
Q3 FY2025136.3reported
Q2 FY2025136.6reported
Q1 FY2025130.5reported
Q4 FY2024124.0derived
Q3 FY2024124.4reported
Q2 FY2024122.2reported
Q1 FY2024119.6reported
Q4 FY2023127.8derived
Q3 FY2023128.8reported
Q2 FY2023141.4reported
Q1 FY2023142.3reported
Q4 FY2022138.5derived
Q3 FY2022138.7reported
Q2 FY2022135.8reported
Q1 FY2022130.3reported
Q4 FY2021124.7derived
Q3 FY2021133.3reported
Q2 FY2021140.5reported
Q1 FY2021114.2reported
Q4 FY2020120.3reported
Q3 FY2020116.0reported
Q2 FY2020109.0reported
Q1 FY202096.0reported
Q4 FY2019102.8reported
Q3 FY2019116.9reported
Q2 FY201996.3reported
Q1 FY201992.0reported
Q4 FY201895.1reported
Q3 FY201894.1reported
Q2 FY201891.1reported
Q1 FY201885.9reported
Q4 FY201785.5reported
Q3 FY201788.6reported
Q2 FY201789.2reported
Q1 FY201787.0reported
Q4 FY201683.7reported
Q3 FY201683.0reported
Q2 FY201686.3reported
Q1 FY201681.1reported

CSV with all sources · Technical ID: rnd

More metrics for F5

Income statement

Per share

Balance sheet

Cash flow

Debt and interest

Revenue by segment/product/region

Sources & calculation
Value
$96.0M
Period
Q2 FY2019, ended Mar 31, 2019 · quarterly value (3 months, not cumulative)
Source
10-Q, filed May 3, 2019 · 0001048695-19-000014
Location
us-gaap:ResearchAndDevelopmentExpense
Confidence
1. – directly from an XBRL fact in the filing (or calculated exactly from it)

Versions

v1$96.0MMay 3, 201910-Q 0001048695-19-000014reported · confidence 1. · current